Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2
- 19 October 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 244, 114857
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Data processing and analysis with theautoPROCtoolboxActa Crystallographica Section D Structural Biology, 2011
- Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Backbone Amide Linker (BAL) Strategy for Solid-Phase Synthesis of C-Terminal-Modified and Cyclic Peptides1,2,3Journal of the American Chemical Society, 1998
- Use of ozonolysis in the synthesis of C-terminal peptide aldehydes on solid supportTetrahedron Letters, 1997
- Solid Phase Synthesis of C-Terminal Peptide AldehydesThe Journal of Organic Chemistry, 1997
- Inhibition studies of some serine and thiol proteinases by new leupeptin analogsJournal of Medicinal Chemistry, 1993
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990
- Enhancement of peptide coupling reactions by 4‐dimethylaminopyridineInternational Journal of Peptide and Protein Research, 1981